Skip to main content
OpenTrials

Clinical trial condition

Anemia, Sickle Cell

Explore clinical trials studying Anemia, Sickle Cell. Study availability and eligibility vary by location and protocol.

843 public trials 154 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Sickle Cell trial results

Completed

A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.

NCT00040677

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +8 more
Locations
  • Study Site Birmingham, Alabama, United States
  • Study Site Oakland, California, United States
  • Study Site San Francisco, California, United States
  • Study Site Washington D.C., District of Columbia, United States
View all 19 locations
View Trial Details
Completed

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

NCT00235391

Conditions
Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +19 more
Locations
  • Arkansas Children's Hospital, UAMS College of Medicine Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital and Health Center of San Diego San Diego, California, United States
View all 141 locations
View Trial Details
Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).

NCT01090323

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of South Alabama College of Medicine Mobile, Alabama, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital & Research Center at Oakland Oakland, California, United States
View all 39 locations
View Trial Details
Completed

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

NCT00110617

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • University of Alabama Pediatric Hematology/Oncology Birmingham, Alabama, United States
  • University of Alabama Medical center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
View all 59 locations
View Trial Details

Related conditions